How to Reach First-in-Man Studies Successfully

September 28, 2012
Angie Drakulich

Angie Drakulich was editorial director of Pharmaceutical Technology.

What’s the best way to reach first-in-man studies when you have little to no information? Bioavailability issues, financial constraints.

What’s the best way to reach first-in-man studies when you have little to no information?   Bioavailability issues, financial constraints, and pressure to meet accelerated deadlines can affect development, so having a firm plan in place is key. PharmTech is hosting a free educational webinar on this topic next week, Oct. 3. Check it out for insight into the signs to look for when finalizing a plan and how to achieve the best outcomes. A detailed case study about a molecule that has successfully navigated through development to commercial success will be presented.

Related Content:

PharmTech Talk